loading page

Median effective does of Ciprofol combined with sufentanil for inhibiting the upper gastrointestinal endoscopic placement reaction
  • +4
  • Haojing Xiong,
  • Hechen Xu,
  • Haibo Chen,
  • Yang Yang,
  • Bailong Hu,
  • Ke Jiang,
  • Xiaohua Zou
Haojing Xiong
Guizhou Medical University
Author Profile
Hechen Xu
Guizhou Medical University
Author Profile
Haibo Chen
Guizhou Medical University
Author Profile
Yang Yang
The Affiliated Hospital of Guizhou Medical University
Author Profile
Bailong Hu
The Affiliated Hospital of Guizhou Medical University
Author Profile
Ke Jiang
The Affiliated Hospital of Guizhou Medical University
Author Profile
Xiaohua Zou
The Affiliated Hospital of Guizhou Medical University

Corresponding Author:[email protected]

Author Profile

Abstract

Objective: Ciprofol combined with sufentanil was used to explore median effective dose and 95% confidence interval for inhibiting the upper gastrointestinal endoscopic insertion response in elderly patients using up-and-down sequential allocation trial, provide a reference for clinical rational drug use. Methods: We studied fifty-seven patients who were scheduled to undergo a diagnostic upper gastrointestinal endoscopy. According to age, it is divided into two groups: 65~74 years old and over 75 years old. Using the modified Dixon sequence test method, intravenous bolus of 0.1 μg/kg sufentanil is given after 3 min before ciprofol is administered, the initial dose of ciprofol is 0.4 mg/kg, the upper gastrointestinal endoscopy is placed after reaching the depth of sedation. Results: In the group A, when combined with 0.1 sufentanil, the ED 50 of ciprofol to inhibiting responses to insertion of upper gastrointestinal endoscopy was 0.23 mg/kg, and the 95% CI was 0.09~0.30 mg/kg; in the group B, the ED 50 was 0.18mg/kg,and the 95% CI was 0.13~0.22mg/kg. Conclusion: The ED 50 of ciprofol in combination with sufentanil (0.1 μg/kg) for upper gastrointestinal endoscopy in elderly patients: 0.23 mg/kg in group A, 0.18 mg/kg in group B.